Perfil glicêmico de pessoas que vivem com HIV/AIDS atendidos no Hospital Universitário Alcides Carneiro.

Abstract

The epidemic of AIDS infection is present globally. In Brazil, in 2015, more than 700,000 new cases of AIDS were registered. Despite the studies to regarding etiopathogenesis, pathophysiology and transmission mechanisms, the prevalence and incidence are still high. With the advent of drugs antiretroviral drugs, the prognosis and quality of life of patients with HIV were significantly improved and morbidity and mortality from the virus and its complications have decreased dramatically. However, the incidence of some non-AIDS-related illnesses, cardiovascular disease and diabetes mellitus, shows a growing trend, and these have become one of the main causes of morbidity in patients with HIV. The aim of the present study was describe the profile of people living with HIV/AIDS and diabetes mellitus treated at the University Hospital Alcides Carneiro during the period from April to August 2017. The population is 56.9% male, with an average age of 47.82 years old, mixed race, single, primary education level, eminently busy. From the behavioral point of view, only three (4.2%) have the practice of routine physical activity. A minority is also a smoker, drinker or uses illicit drugs. From the clinical-laboratory point of view, the patients present an average time since diagnosis of HIV infection of 8.98 years; 72.2% are under the use of antiretroviral drugs for more than three years and 43% of them under regimen containing protease inhibitors. Patients have good virological control and immune system, 72% with suppressed viral load and almost 90% with CD4+ T lymphocytes above 200 cels̸mm3. Only three (4.2%) patients were identified as having diabetes mellitus and one (1.4%) with intolerance to glucose in the studied population. However, the high frequency of medical records in whose data regarding the glycemic profile were absent did not allow us to infer plausible conclusions. Larger studies with the current population, in particular prospective studies, should be performed so that a better glycemic profile can be traced. From now on, this work contributes with the suggestion of establishing a screening routine and recording of specific items related to the glycemic profile having with a view to reducing possible morbidities associated with antiretroviral therapy.